Commodity	Region/indoor a	Residue levels observed in the supervised residue trials (mg/kg) b	Comments/source	Calculated MRL (mg/kg)	HR c (mg/kg)	STMR d (mg/kg)	CF e
Residue trials supporting adjusted and new GAPs considered for the confirmatory data assessment
Lettuces and salad plants	SEU	3 × < 0.005; 0.005; 0.011; 2 × < 0.02; 0.074	GAP on propaquizafop assessed in a previous MRL opinion (EFSA, 2019b). Sufficient residue trials on open leaf lettuce varieties compliant with GAP are available to derive an MRL proposal for whole group of lettuces and salad plants	0.15	0.074	0.01	–
Spinach	SEU	3 × < 0.005; 0.005; 0.011; 2 × < 0.02; 0.074	Direct extrapolation from the trials performed on open leaves varieties of lettuce (see above, EFSA, 2019b), compliant with the southern GAP on spinach for propaquizafop, reported during the MRL review	0.15	0.074	0.01	‐
Caraway seeds	NEU	2 × < 0.01; 2 × 0.02	A new GAP for quizalofop‐p‐ethyl was reported and assessed under Article 10 of Regulation (EC) No 396/2005. The confirmatory data requirements on residue trials, analytical methods and storage stability for caraway could be considered as sufficiently addressed (EFSA, 2021)	0.04	0.02	0.02	–
Residue trials supporting the intended new MRLs based on new GAPs on quizalofop‐P‐tefuryl (Art 10)
Table grapes	NEU	3 × < 0.04	All results below the LOQ (Croatia, 2023). No MRL change proposed	–	–	–	–
Sunflower seeds	NEU	0.02, 0.04, 0.10, 0.25, 0.26, 0.43, 0.48, 0.83	Residue trials on sunflower seeds compliant with GAP (Croatia, 2023; EFSA, 2017)	1.5	0.83	0.26	–
Soyabeans	NEU	0.02; 0.03; 3 × 0.04; 0.05; 0.16; 0.17	Residue trials on soyabeans compliant with GAP (Croatia, 2023; EFSA, 2017)	0.3	0.17	0.04	–

Note: All the results are reported as sum of quizalofop‐P‐tefuryl and free and conjugated metabolites that can be converted to 2‐methoxy‐6‐chloroquinoxaline (MCQ), expressed as quizalofop acid.

Abbreviations: GAP, Good Agricultural Practice; Mo, monitoring; MRL, maximum residue level; RA, risk assessment.

^*Indicates that the MRL is proposed at the limit of quantification.

^a NEU: Outdoor trials conducted in northern Europe, SEU: Outdoor trials conducted in southern Europe, Indoor: indoor EU trials or Country code: if non‐EU trials.

^b mg/kg expressed as quizalofop equivalents. RDMO = RDRA (Sum of quizalofop, its salts, its esters (including propaquizafop) and its conjugates, expressed as quizalofop (any ratio of constituent isomers)

^c Highest residue. The highest residue for risk assessment refers to the whole commodity and not to the edible portion.

^d Supervised trials median residue. The median residue for risk assessment refers to the whole commodity and not to the edible portion.

^e Conversion factor to recalculate residues according to the residue definition for monitoring to the residue definition for risk assessment.